ASX - By Stock
|
MSB |
Re:
Cup and Handle Chart Pattern
|
|
Wazza222
|
249 |
55K |
2 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
249
|
55K
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Wazza222
|
82K |
49M |
2 |
13/03/21 |
13/03/21 |
ASX - By Stock
|
82K
|
49M
|
2
|
|
ASX - By Stock
|
AVR |
Re:
"Toot Toot"
|
|
Wazza222
|
439 |
125K |
2 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
439
|
125K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
"Toot Toot"
|
|
Wazza222
|
439 |
125K |
1 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
439
|
125K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
CEO presentation - one of the best I have seen.
|
|
Wazza222
|
63 |
17K |
3 |
06/03/21 |
06/03/21 |
ASX - By Stock
|
63
|
17K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
Wazza222
|
508 |
172K |
3 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
172K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Wazza222
|
1.1K |
313K |
1 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
Wazza222
|
49 |
13K |
2 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
49
|
13K
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Wazza222
|
82K |
49M |
19 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
82K
|
49M
|
19
|
|
ASX - By Stock
|
AVZ |
Re:
"German Refining Facility" in AVZ carbon footprint report
|
|
Wazza222
|
129 |
54K |
10 |
24/01/21 |
24/01/21 |
ASX - By Stock
|
129
|
54K
|
10
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Appendix 2A and Section 708A Notice
|
|
Wazza222
|
17 |
8.2K |
5 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
17
|
8.2K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
Wazza222
|
416 |
132K |
2 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
416
|
132K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
Wazza222
|
416 |
132K |
1 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
416
|
132K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wazza222
|
5.4K |
2.6M |
1 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
5.4K
|
2.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
Wazza222
|
572 |
251K |
5 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
251K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wazza222
|
17K |
6.7M |
3 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Hart-Scott-Rodino Antitrust Improvements Act
|
|
Wazza222
|
20 |
7.5K |
4 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
20
|
7.5K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Hart-Scott-Rodino Antitrust Improvements Act
|
|
Wazza222
|
20 |
7.5K |
4 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
20
|
7.5K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Hart-Scott-Rodino Antitrust Improvements Act
|
|
Wazza222
|
20 |
7.5K |
9 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
20
|
7.5K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Hart-Scott-Rodino Antitrust Improvements Act
|
|
Wazza222
|
20 |
7.5K |
3 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
20
|
7.5K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update and Financial Results Webcast
|
|
Wazza222
|
51 |
19K |
10 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
51
|
19K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Quarter Financial Results on Form 6-K
|
|
Wazza222
|
9 |
4.7K |
5 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
9
|
4.7K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update and Financial Results Webcast
|
|
Wazza222
|
51 |
19K |
2 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
51
|
19K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update and Financial Results Webcast
|
|
Wazza222
|
51 |
19K |
9 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
51
|
19K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Wazza222
|
13K |
5.0M |
6 |
14/11/20 |
14/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
trump taken to hospital
|
|
Wazza222
|
264 |
109K |
4 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
264
|
109K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Wazza222
|
635 |
277K |
32 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
635
|
277K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Wazza222
|
635 |
277K |
0 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
277K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ulcerative Colitis Clinical Trial
|
|
Wazza222
|
23 |
9.5K |
14 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
23
|
9.5K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wazza222
|
17K |
6.7M |
2 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
Wazza222
|
3.1K |
1.4M |
2 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
What the hell is Convalescent plasma therapy
|
|
Wazza222
|
41 |
18K |
0 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
41
|
18K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Pick the Closing Price after FDA approval on that day
|
|
Wazza222
|
449 |
189K |
4 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
449
|
189K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Wazza222
|
15 |
9.2K |
4 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
15
|
9.2K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Wazza222
|
23K |
13M |
1 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wazza222
|
17K |
6.7M |
2 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wazza222
|
17K |
6.7M |
5 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Wazza222
|
23K |
13M |
29 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
23K
|
13M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wazza222
|
17K |
6.7M |
50 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
17K
|
6.7M
|
50
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Wazza222
|
9.8K |
2.9M |
1 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
9.8K
|
2.9M
|
1
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
Wazza222
|
888 |
644K |
35 |
11/06/20 |
11/06/20 |
Charts
|
888
|
644K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Nasdaq
|
|
Wazza222
|
1 |
963 |
1 |
06/06/20 |
06/06/20 |
ASX - By Stock
|
1
|
963
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Wazza222
|
23K |
13M |
4 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Pick the Closing Price after FDA approval on that day
|
|
Wazza222
|
449 |
189K |
1 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
449
|
189K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
Wazza222
|
518 |
264K |
3 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
518
|
264K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Completes Financing For Covid-19 ARDS Manufacturing
|
|
Wazza222
|
116 |
58K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
116
|
58K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast gets one more roll of the dice
|
|
Wazza222
|
79 |
45K |
28 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
79
|
45K
|
28
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic
|
|
Wazza222
|
195 |
82K |
2 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
195
|
82K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic
|
|
Wazza222
|
195 |
82K |
0 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
195
|
82K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wazza222
|
17K |
6.7M |
7 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|